Spun out of Inesc Tec under a strategic agreement with Frontier IP, Insignals hopes to commercialise a surgical guidance device for brain implants to treat conditions including Parkinson's.

Commercialisation firm Frontier IP on Tuesday unveiled Insignals Neurotech, a Portugal-based spinout of Portuguese Institute for Systems and Computer Engineering, Technology and Science (Inesc Tec), to develop a surgical guidance system for brain implants. Frontier IP will own a 33% stake in Insignals Neurotech, the third venture to emerge from its pipeline based on strategic…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.